Skip to main content

Table 5 Aggregate results of the Working Group 3 and Working Group 4 and comparison of differences between the stakeholder groups

From: Evaluation of dialysis centres: values and criteria of the stakeholders

 PatientsCliniciansManagersPatients/
Clinicians
Patients/
Managers
Clinicians/
Managers
(n = 25)(n = 33)(n = 27)   
Mean (SD)Mean (SD)Mean (SD)P-valueP-valueP-value
CriteriaSub-criteria      
Evidence-based variables 24.00 (8.16)24.91 (9.53)25.11 (10.34)1.0001.0001.000
 Type of vascular access29 .00 (9.01)27.66 (7.32)28.70 (8.03)1.0001.0001.000
 Dialysis dose23.52 (8.12)23.84 (5.83)22.03 (6.24)1.0001.0000.903
 Haemoglobin concentration15.64 (4.85)16.24 (3.79)15.74 (3.31)1.0001.0001.000
 Ratio of bacteraemia related to the catheter17.00 (8.66)20.60 (5.57)22.77 (5.60)0.1310.007*0.633
 Mineral and bone disease14.84 (6.75)11.63 (5.52)10.74 (4.94)0.1160.036*1.000
Morbidity, annual15.00 (8.16)17.42 (5.60)19.70 (6.82)0.5510.045*0.604
Mortality, annual13.40 (7.03)15.63 (6.09)17.48 (8.51)0.7350.1330.98
PROMs29.4 (7.68)24.54 (6.54)24.15 (7.81)0.042*0.034*1.000
PREMs18.20 (8.89)17.48 (5.75)13.18 (4.86)1.0000.023*0.042*
  1. PROM patient reported outcome measure, PREM patient reported experience measure, SD standard deviation
  2. *p < 0.05